BPC-157 & TB-500 40mg – Premium Research-Grade Peptide Combination
⚠️ CRITICAL REGULATORY STATUS
READ BEFORE PROCEEDING:
- FDA Status: BPC-157 and TB-500 are classified as Category 2 bulk drug substances by the FDA. They are NOT approved for human therapeutic use.
- WADA Prohibition: Both peptides are banned by the World Anti-Doping Agency under S0: Unapproved Substances.
- Compounding Ban: Commercial pharmaceutical compounding of these substances is prohibited in the United States.
- Research Only: These peptides are EXCLUSIVELY for qualified laboratory research purposes.
- Legal Risk: Misuse for human consumption may result in legal consequences and health risks.
Introduction to BPC-157 & TB-500 Research Peptides
BPC-157 & TB-500 40mg represents a dual-peptide research formulation designed for qualified laboratories conducting investigations into tissue repair mechanisms, cellular migration pathways, and angiogenesis. These synthetic peptides have gained attention in preclinical research for their distinct biological mechanisms and potential synergistic effects.
Manufactured under rigorously controlled conditions, our BPC-157 & TB-500 40mg combination is intended exclusively for laboratory research, analytical testing, and mechanistic studies—never for human or veterinary consumption.
Important Research Context
While these peptides have shown promising results in animal studies, it is critical to understand:
- Human clinical data is extremely limited
- Long-term safety profiles are unknown
- Regulatory approval for therapeutic use does not exist
- All evidence comes from preclinical laboratory models
Product Specifications: BPC-157 & TB-500 40mg
| Specification | BPC-157 | TB-500 |
|---|---|---|
| Chemical Name | Body Protection Compound-157 | Thymosin Beta-4 Fragment |
| Amino Acid Sequence | Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val (15 amino acids) | Ac-LKKTETQ (7 amino acids, N-terminal acetylated) |
| Molecular Weight | ~1,419 Da | ~889 Da |
| Strength per Vial | 20mg BPC-157 | 20mg TB-500 |
| Total Combination | 40mg total peptide content (20mg each) | |
| Grade Classification | Research Use Only (RUO) | |
| Form | Lyophilized peptide powder | |
| Purity Level | ≥98% each peptide (HPLC verified, COA provided per batch) | |
| Intended Application | Laboratory & R&D use only – NOT for human or veterinary consumption | |
| Storage Conditions | -20°C to -80°C (lyophilized form) | |
Each batch undergoes comprehensive quality control testing including HPLC purity verification, mass spectrometry identification, and sterility testing to ensure researchers receive materials that meet the highest industry standards.
Understanding BPC-157 & TB-500: Mechanisms and Origins
BPC-157: Gastric Pentadecapeptide
BPC-157 (Body Protection Compound-157) is a synthetic 15-amino-acid peptide derived from a naturally occurring protein found in human gastric juice. Originally isolated during research on gastric secretions, this pentadecapeptide has become a focal point in tissue repair research.
Proposed Mechanisms of Action
Research in animal models suggests BPC-157 operates through several interconnected pathways:
- VEGF Receptor 2 (VEGFR2) Activation: Primary pathway for angiogenesis and new blood vessel formation
- Growth Hormone Receptor Upregulation: Dose-dependent increases in tendon fibroblast growth hormone receptor expression
- Focal Adhesion Kinase (FAK)-Paxillin Pathway: Facilitates cell migration and attachment to surfaces during wound healing
- JAK-2 Signaling: Relays signals for cell survival, growth, and immune responses
- Early Growth Response Gene 1 (Egr-1): Acts as a master switch for genes involved in cell growth and blood vessel formation
- ERK1/2 Pathway: Involved in cellular proliferation and differentiation
- Nitric Oxide (NO) Modulation: Regulates vascular function and inflammatory responses
Critical Research Limitations
Despite promising preclinical findings, researchers must note:
- Almost all studies are limited to rodent models (rats and mice)
- No completed Phase III clinical trials exist
- The mechanism of action is not fully understood
- Human pharmacokinetics are largely unknown
- Potential adverse effects in humans remain unstudied
TB-500: Thymosin Beta-4 Fragment
TB-500 is a synthetic 7-amino-acid fragment (Ac-LKKTETQ) corresponding to the actin-binding region of thymosin beta-4 (Tβ4), a naturally occurring 43-amino-acid peptide found in nearly all human cells. First isolated from thymus tissue, thymosin beta-4 plays fundamental roles in cytoskeletal organization.
Proposed Mechanisms of Action
Laboratory research indicates TB-500 functions primarily through:
- G-Actin Sequestration: Binds monomeric actin, preventing premature polymerization and maintaining actin pools for rapid cytoskeletal reorganization
- Enhanced Cellular Migration: Facilitates cell movement essential for wound healing and tissue repair
- Angiogenesis Promotion: Upregulates VEGF expression and enhances endothelial cell sprouting
- Anti-inflammatory Effects: Reduces pro-inflammatory cytokines (TNF-α, IL-1β, IL-6)
- ILK-Akt Pathway Activation: Supports cell survival and inhibits apoptosis
- Collagen Organization: Influences extracellular matrix remodeling
TB-500 vs. Full-Length Thymosin Beta-4
Important distinctions for researchers:
- TB-500 contains only the actin-binding motif (7 amino acids)
- Full thymosin beta-4 is 43 amino acids with additional functional domains
- TB-500 is a targeted probe for actin-related behavior only
- Full Tβ4 may have broader biological effects not replicated by TB-500
- Research findings may not be directly comparable between the two forms
Research Applications for BPC-157 & TB-500
Individual Peptide Research Areas
BPC-157 Research Applications
- Tendon and ligament injury models in rodents
- Muscle detachment and healing studies
- Gastric mucosal protection research
- Vascular occlusion syndrome models
- Bone healing and fracture recovery studies
- Neuromuscular junction stabilization research
- VEGFR2 signaling pathway investigations
- Growth hormone receptor expression studies
TB-500 Research Applications
- Actin polymerization and cytoskeletal dynamics
- Cell migration assays and wound healing models
- Corneal wound healing research
- Dermal wound closure studies
- Cardiac tissue repair models post-ischemia
- Angiogenesis pathway investigations
- Anti-inflammatory mechanism studies
- Fibroblast activity and collagen synthesis research
Combined Research Investigations
Researchers have explored combining BPC-157 and TB-500 based on their complementary mechanisms:
- Synergistic Pathway Analysis: Investigating how VEGF-mediated angiogenesis (both peptides) combines with unique mechanisms
- Comparative Efficacy Studies: Evaluating single vs. combination peptide effects in tissue repair models
- Multi-Modal Tissue Repair: Examining combined effects on fibroblast activity, collagen synthesis, and vascular regeneration
- Dose-Response Optimization: Determining optimal ratios and concentrations for laboratory studies
Publication Bias Alert
Researchers should be aware that published studies on BPC-157 and TB-500 show a strong positive bias. Nearly all published research reports beneficial effects, suggesting possible:
- Selective publication of positive results
- Insufficient reporting of failed experiments
- Limited reproducibility data from independent laboratories
- Potential conflicts of interest in some research groups
Bulk Supply & Wholesale Program for Research Institutions
The BPC-157 & TB-500 40mg formulation is available through our specialized bulk supply program, designed exclusively for qualified research organizations with appropriate credentials and oversight.
Qualified Buyer Categories
- Academic research laboratories and university research centers
- Pharmaceutical R&D facilities conducting preclinical studies
- Biotechnology companies with peptide research programs
- Contract research organizations (CROs) specializing in tissue repair mechanisms
- Quality control and analytical testing laboratories
- Peptide synthesis and characterization facilities
Note: Clinics, wellness centers, compounding pharmacies, and direct-to-consumer sellers are NOT eligible for purchase due to regulatory restrictions.
Flexible Quantity Tiers
- Starter Research Tier: 10-50 vials for pilot studies and method development
- Standard Research Tier: 51-200 vials for ongoing research programs
- Large-Scale Tier: 201-500 vials for comprehensive preclinical studies
- Enterprise Tier: 500+ vials for multi-site research programs (subject to enhanced due diligence)
Quality Assurance Guarantees
- Batch-to-Batch Consistency: Validated manufacturing protocols ensure reproducible research results
- Dual Certificate of Analysis: Separate HPLC and MS verification for each peptide
- Stability Data: Accelerated and real-time stability testing under various conditions
- Lot Traceability: Complete chain-of-custody documentation from synthesis to delivery
- GMP-Style Manufacturing: Production in ISO-certified facilities with full audit trails
BPC-157 vs. TB-500: Mechanisms & Potential Synergy
| Parameter | BPC-157 | TB-500 |
|---|---|---|
| Origin | Derived from gastric protein BPC | Fragment of thymosin beta-4 |
| Amino Acid Length | 15 amino acids (pentadecapeptide) | 7 amino acids (heptapeptide) |
| Primary Mechanism | VEGFR2 activation, growth factor modulation | Actin sequestration, cytoskeletal regulation |
| Stability | Stable in gastric juice >24 hours | N-terminal acetylation provides stability |
| Half-Life | Unknown in humans; <30 min in rodents (IV/IM) | <30 minutes (IV/IM) |
| Primary Research Focus | Tissue healing, vascular protection, GI repair | Cell migration, wound healing, actin dynamics |
| Angiogenesis | Via VEGFR2 pathway | Via VEGF upregulation |
| Human Clinical Data | Very limited (small case series only) | Very limited (venous stasis ulcer trial) |
| FDA Status | Category 2 bulk drug (prohibited from compounding) | Category 2 bulk drug (prohibited from compounding) |
| WADA Status | Banned (S0: Unapproved Substances) | Banned (S0: Unapproved Substances) |
Theoretical Synergy in Laboratory Models
Researchers have hypothesized potential synergistic effects based on complementary mechanisms:
- Dual Angiogenic Stimulation: BPC-157’s VEGFR2 activation + TB-500’s VEGF upregulation
- Enhanced Cellular Migration: TB-500’s actin regulation combined with BPC-157’s FAK-paxillin activation
- Multi-Pathway Growth Factor Modulation: BPC-157’s GH receptor effects + TB-500’s ILK-Akt signaling
- Complementary Anti-Inflammatory Actions: Different but potentially additive pathways
Critical Research Gap
Despite widespread anecdotal combination use, there is minimal controlled research specifically investigating BPC-157 + TB-500 synergy. One small human case series (Lee & Padgett, 2021) reported outcomes from combined intra-articular knee injections but lacked control groups, standardized assessment, and was published by practitioners selling the treatment—presenting clear conflicts of interest.
Quality Documentation & Analytical Standards
Comprehensive Documentation Package
Each shipment of BPC-157 & TB-500 40mg includes:
Dual Certificates of Analysis (COA)
Separate COAs for each peptide containing:
- HPLC Purity Analysis: Chromatographic verification ≥98% for each peptide
- Mass Spectrometry: Molecular weight confirmation and sequence verification
- Peptide Content: Quantitative assay of active peptide concentration
- Moisture Content: Karl Fischer analysis for lyophilized powder quality
- Microbial Testing: Sterility confirmation via USP methods
- Endotoxin Levels: LAL testing for biological research applications
- pH Analysis: Post-reconstitution pH verification
- Residual Solvents: GC analysis ensuring synthesis by-product removal
Supporting Documentation
- Material Safety Data Sheets (MSDS/SDS): Complete safety, handling, and disposal information for both peptides
- Reconstitution Protocols: Detailed guidelines for proper solubilization
- Storage Guidelines: Temperature, light, and moisture protection recommendations
- Stability Data: Shelf-life and degradation studies
- Amino Acid Sequence Verification: Confirming correct synthesis
Ordering Process for Qualified Researchers
Step 1: Initial Qualification Inquiry
Contact our research supply division at support@buyalluviretatrutide.co.uk with:
- Institution name and research focus area
- Principal investigator credentials and ORCID ID
- Institutional review board (IRB) or ethics committee approval (if applicable)
- Specific research protocols and intended use
- Estimated quantity requirements
- Delivery location and timeline
Step 2: Enhanced Due Diligence
Due to regulatory scrutiny, all buyers must provide:
- Institutional registration and research facility documentation
- Laboratory accreditation certificates
- End-Use Declaration: Legally binding statement confirming research-only use and prohibition of human/veterinary application
- Compliance attestation regarding FDA, WADA, and local regulations
- Institutional biosafety and chemical safety protocols
- Confirmation of qualified personnel and proper storage facilities
Prohibited Purchaser Categories
We cannot and will not sell to:
- Individual consumers or personal use buyers
- Wellness clinics or anti-aging practices
- Compounding pharmacies (due to FDA Category 2 status)
- Sports medicine facilities offering direct patient treatment
- Entities without verifiable research credentials
- Organizations in jurisdictions where these peptides are prohibited
Step 3: Order Approval & Processing
Upon qualification approval:
- Receive volume-based pricing schedule
- Review minimum order quantities and payment terms
- Complete purchase order with legal attestations
- Arrange secure payment and shipping logistics
- Receive order tracking and cold-chain monitoring information
Pricing & Cost Considerations
Pricing Structure
Factors affecting BPC-157 & TB-500 40mg pricing:
- Order Volume: Significant discounts at higher quantity tiers
- Purity Specifications: ≥98% purity commands premium pricing
- Combination Formulation: Dual-peptide products require additional QC
- Geographic Location: Domestic vs. international shipping considerations
- Documentation Requirements: Enhanced COA packages available
- Standing Orders: Scheduled deliveries may receive preferential rates
Total Cost of Ownership
When evaluating suppliers, consider:
- Documented purity reducing experimental failures
- Batch-to-batch consistency minimizing protocol adjustments
- Reliable delivery schedules preventing research delays
- Technical support reducing troubleshooting time
- Proper cold-chain handling ensuring peptide stability
- Comprehensive documentation supporting publications and grant applications
Request detailed pricing by contacting our wholesale team at support@buyalluviretatrutide.co.uk with your specific requirements and institutional credentials.
Packaging, Storage & Logistics Excellence
Pharmaceutical-Grade Packaging
Primary Packaging
- Type I borosilicate glass vials (USP/Ph.Eur. compliant)
- Separate vials for each peptide to prevent cross-contamination
- Lyophilized rubber stoppers meeting pharmaceutical standards
- Aluminum crimp seals with tamper-evident features
- Nitrogen backfilling to minimize oxidation
Secondary Packaging
- Moisture-barrier foil pouches with integrated desiccants
- Individual packaging for each peptide maintaining identity
- Impact-resistant cushioning for transit protection
- Temperature monitoring labels (time-temperature integrators)
- Discreet labeling: “Research Material – Not for Human Use”
Optimal Storage Conditions
| Storage Phase | Temperature | Duration | Additional Considerations |
|---|---|---|---|
| Lyophilized (Sealed) | -20°C to -80°C | 24-36 months | Protect from light and moisture |
| Reconstituted Solution | 2-8°C | 7-14 days max | Aliquot to avoid freeze-thaw cycles |
| Working Aliquots | -20°C | Use within 1 month | Single-use aliquots preferred |
Cold-Chain Logistics
- Validated pharmaceutical cold-chain carriers
- Dry ice packaging with calculated sublimation rates
- Real-time temperature data loggers with post-delivery reports
- Insurance coverage for high-value research materials
- Signature-required delivery to authorized personnel only
International Shipping Compliance
- Export documentation and customs clearance support
- HS code classification assistance (peptide research materials)
- Import permit coordination where required
- Verification of destination country regulations
- Enhanced documentation for controlled jurisdictions
Regulatory Compliance & Legal Status
⚠️ CRITICAL REGULATORY INFORMATION
FDA Status (United States)
- Category 2 Bulk Drug Substances: Both BPC-157 and TB-500 are classified as Category 2, meaning insufficient evidence exists to determine safety for human use
- Compounding Prohibition: Commercial pharmaceutical compounding is explicitly prohibited as of September 2023
- No Approved Indications: Neither peptide has FDA approval for any therapeutic use
- Not GRAS: Not recognized as “Generally Regarded as Safe” for dietary supplements
- Research Chemical Only: Legal sale restricted to research purposes with explicit “not for human consumption” labeling
WADA Prohibition (Athletic Use)
- S0 Category: Banned under “Unapproved Substances” since 2022
- In-Competition and Out-of-Competition: Prohibited at all times
- Detection Methods: Both peptides and their metabolites are detectable in anti-doping testing
- Athlete Consequences: Use results in sanctions, suspensions, and career damage
International Regulatory Variation
- European Union: Not approved by EMA; regulations vary by member state
- Canada: Not approved by Health Canada; considered unapproved drugs
- Australia: Regulated by TGA; classified as prescription-only but not approved for any indication
- United Kingdom: Not MHRA approved; available only for research purposes
Buyer Responsibilities & Legal Obligations
All purchasers must:
- Maintain appropriate institutional research credentials and oversight
- Sign legally binding end-use declarations prohibiting human/veterinary use
- Comply with all applicable federal, state/provincial, and local regulations
- Implement proper laboratory safety protocols and researcher training
- Maintain detailed records of research applications and chain of custody
- Ensure proper hazardous waste disposal according to regulations
- Never distribute, market, or sell peptides for human consumption or therapeutic use
- Report any adverse events or safety concerns to appropriate authorities
Legal Risks & Enforcement Actions
Potential consequences of misuse:
- FDA enforcement actions against unauthorized human use
- Criminal prosecution for misbranding or unapproved drug distribution
- Professional license revocation for healthcare practitioners
- Civil liability for adverse health outcomes
- Product seizure and facility shutdown
- Import/export violations and customs penalties
ALLUVI Compliance Commitment
We maintain strict compliance by:
- Rigorous buyer qualification and credential verification
- Legally binding purchase agreements with end-use restrictions
- Clear “Research Use Only” and “Not for Human Consumption” labeling
- Refusal to sell to unqualified or suspicious buyers
- Cooperation with regulatory authorities as required
- Regular legal review of compliance programs
- Transparent documentation and audit trails
Safety Concerns & Risk Profile
⚠️ Limited Human Safety Data
Critical gaps in safety knowledge include:
- No completed randomized controlled trials in humans
- Unknown long-term effects and toxicity profiles
- Unclear drug interactions and contraindications
- Limited pharmacokinetic and pharmacodynamic data
- Absence of dose-ranging safety studies
- No systematic adverse event reporting systems
Theoretical Safety Concerns Based on Mechanism
Angiogenesis-Related Risks (Both Peptides)
Since both BPC-157 and TB-500 promote blood vessel formation, theoretical concerns include:
- Cancer Risk: Angiogenesis is critical for tumor growth and metastasis. Use in individuals with undetected cancer could theoretically accelerate disease progression
- Diabetic Retinopathy: Abnormal blood vessel growth in the retina
- Cardiovascular Effects: Unknown impacts on existing vascular pathologies
Cancer Considerations
Multiple researchers have expressed concern:
“Using BPC-157 may not be the right choice, especially in situations where we are not aware of the presence of cancer cells in our body.” (Scientific literature review)
No clinical trials have evaluated tumor promotion risk. The theoretical concern is based on mechanism, not observed cases, because human exposure data is insufficient.
Immunogenicity Concerns
FDA has specifically cited concerns about:
- Potential immune system reactions to foreign peptides
- Antibody formation against the peptides
- Peptide impurities triggering immune responses
- Lack of characterization of active ingredients in many products
Reported Anecdotal Adverse Effects
Anonymous online users have reported (unverified):
- Injection site pain, swelling, and inflammation
- Joint pain and stiffness
- Anxiety and panic attacks
- Heart palpitations
- Sleep disturbances (insomnia or drowsiness)
- Weakness and fatigue
- Loss of appetite
- Mood changes (depression, anhedonia)
Product Quality & Contamination Risks
Research from supplement contamination studies indicates:
- 12-58% of “research chemical” supplements contain unlisted substances
- Variable peptide purity and concentration vs. label claims
- Bacterial endotoxin contamination in some products
- Heavy metal impurities in unregulated sources
- Incorrect amino acid sequences due to synthesis errors
This underscores the critical importance of purchasing only from suppliers providing comprehensive COAs and operating under GMP-style conditions.
Technical Support & Research Resources
Dedicated Research Support
ALLUVI provides comprehensive technical assistance to qualified bulk purchasers:
Reconstitution & Preparation
- Solvent recommendations (bacteriostatic water, sterile PBS, etc.)
- Optimal concentration calculations for specific assays
- pH adjustment protocols when required
- Aliquoting strategies to minimize degradation
- Mixing techniques preventing aggregation
Analytical Method Support
- HPLC method optimization for peptide quantification
- LC-MS parameters for identity confirmation
- Bioassay development consultation
- Reference standard preparation guidance
- Stability testing protocol recommendations
Storage & Handling Optimization
- Temperature cycling studies and recommendations
- Freeze-thaw stability data and best practices
- Light and oxidation protection strategies
- Troubleshooting precipitation or cloudiness issues
Scientific Literature Resources
Key peer-reviewed resources for researchers:
- PubMed/MEDLINE: Search “BPC-157” or “Thymosin Beta-4” for latest publications
- Systematic Reviews:
- “Emerging Use of BPC-157 in Orthopaedic Sports Medicine” (2024)
- “Regeneration or Risk? A Narrative Review of BPC-157” (2024)
- Mechanism Studies:
- BPC 157 VEGFR2 pathway research (PMC articles)
- Thymosin beta-4 actin sequestration mechanisms
- Critical Safety Literature:
- FDA Category 2 bulk drug guidance documents
- WADA prohibited substances documentation
- “BPC-157: Miracle Healing Peptide or Hidden Danger?” critical review
Frequently Asked Questions
Can I use BPC-157 & TB-500 for personal injury recovery?
NO. These peptides are NOT approved for human use. They are research chemicals only. Using them for personal treatment:
- Violates FDA regulations
- Exposes you to unknown safety risks
- May be illegal in your jurisdiction
- Disqualifies athletes from competition
Are these peptides legal?
The legal status is complex:
- Legal for research: Yes, when sold with “research use only” labeling to qualified laboratories
- Legal for human consumption: No, explicitly prohibited
- Legal for compounding: No, FDA Category 2 status prohibits pharmaceutical compounding
- Legal for athletes: No, banned by WADA
What documentation proves this is for legitimate research?
Required documentation includes:
- Institutional affiliation and research credentials
- Principal investigator qualifications
- IRB approval or ethics committee review (for certain studies)
- Detailed research protocol and specific aims
- End-use declaration signed by authorized official
- Facility certifications and safety protocols
How pure are these peptides?
Each peptide is verified at ≥98% purity via HPLC with:
- Mass spectrometry confirmation of molecular weight
- Sequence verification
- Comprehensive impurity profiling
- Batch-specific COA provided with every order
What is the shelf life?
When stored properly at -20°C to -80°C:
- Lyophilized form: 24-36 months (batch-specific data in COA)
- After reconstitution at 2-8°C: 7-14 days maximum
- Frozen aliquots at -20°C: Use within 1 month
Can I combine BPC-157 and TB-500 in the same solution?
Research protocols vary, but considerations include:
- Peptide stability at different pH levels
- Potential interactions in solution (limited data)
- Individual reconstitution typically recommended for research flexibility
- Consult technical support for specific application guidance
Why can’t compounding pharmacies use these anymore?
In September 2023, FDA classified both as Category 2 bulk drug substances, citing:
- Insufficient human safety data
- Immunogenicity concerns
- Peptide impurity and characterization challenges
- Lack of clinical approval for any indication
This effectively prohibits legal compounding for patient use in the United States.
What happens if I’m caught using these as an athlete?
WADA consequences include:
- 4-year ban for first violation (potentially reduced with cooperation)
- Lifetime ban for second violation
- Disqualification of competitive results
- Forfeiture of medals and prize money
- Severe reputational damage
How do I know if my research institution is qualified to purchase?
Qualified institutions typically have:
- Established research mission and publication history
- Institutional biosafety or chemical safety committees
- Laboratory accreditation (ISO, CLIA, or equivalent)
- Documented research oversight processes
- Proper chemical storage and handling facilities
- Qualified scientific personnel
Contact us to discuss your specific situation.
What technical support is available after purchase?
We provide:
- Reconstitution and storage guidance
- Analytical method consultation
- Troubleshooting assistance
- Literature and protocol references
- Email and scheduled video support
Why Choose ALLUVI for Research Peptide Supply
Uncompromising Quality & Transparency
- Pharmaceutical-Grade Manufacturing: ISO-certified facilities with validated processes
- Rigorous Testing: HPLC, MS, sterility, endotoxin, and impurity analysis
- Comprehensive Documentation: Detailed COAs and technical data packages
- Batch-to-Batch Consistency: Reproducible results for reliable research
- Full Traceability: Complete chain-of-custody from synthesis to delivery
Ethical & Compliant Operations
- Strict Buyer Qualification: We verify credentials and refuse questionable orders
- Clear Regulatory Positioning: Honest about legal status and limitations
- No False Claims: We do not make therapeutic claims or encourage misuse
- Cooperation with Authorities: Transparent operations and regulatory compliance
- Educational Approach: Providing researchers with complete safety information
Research Partnership Commitment
- Technical expertise in peptide chemistry and handling
- Responsive support from PhD-level scientists
- Flexible ordering to accommodate evolving research needs
- Long-term supply agreements for multi-year studies
- Consultation on experimental design and method development
Competitive Advantages
| Feature | ALLUVI Standard |
|---|---|
| Purity Guarantee | ≥98% HPLC verified for both peptides |
| Dual COA | Separate comprehensive analysis for each peptide |
| Regulatory Compliance | Full adherence to research material regulations |
| Cold-Chain Integrity | Validated logistics with temperature monitoring |
| Technical Support | PhD-level consultation and troubleshooting |
| Ethical Operations | Transparent about risks, limitations, and legal status |
Get Started with Research-Grade BPC-157 & TB-500
If you are a qualified research institution conducting legitimate laboratory investigations into tissue repair mechanisms, cellular migration, angiogenesis pathways, or related fields, ALLUVI can provide the high-quality peptide materials and technical support your work demands.
Next Steps for Qualified Researchers
- Review Regulatory Status: Ensure your research complies with applicable regulations
- Prepare Documentation: Gather institutional credentials, research protocols, and IRB approvals
- Contact Our Team: Email support@buyalluviretatrutide.co.uk with qualification information
- Complete Due Diligence: Submit required documentation and end-use declarations
- Receive Pricing: Review volume-based pricing and terms
- Place Order: Complete legally binding purchase agreement
- Receive Shipment: Accept delivery with comprehensive documentation
- Access Support: Utilize technical consultation for optimal research outcomes
Ready to Discuss Your Research Needs?
Contact our research supply team to:
- Verify your institutional qualifications
- Discuss specific research applications and requirements
- Request detailed pricing for your quantity needs
- Establish long-term supply agreements for ongoing programs
- Schedule technical consultation with peptide chemistry experts
Important Disclaimers & Legal Notices
Research Use Only – Comprehensive Legal Disclaimer
BPC-157 & TB-500 40mg are manufactured and sold exclusively for research and development purposes in qualified laboratory settings.
- Not Approved Drugs: These products are not FDA-approved, EMA-approved, or otherwise authorized pharmaceutical drugs for any indication.
- Not for Human Use: Not intended for human consumption, diagnostic use, therapeutic application, or any medical purpose.
- Not for Veterinary Use: Not approved for animal treatment or veterinary medicine.
- No Medical Claims: No claims are made or implied regarding therapeutic, diagnostic, preventive, or health benefits of any kind.
- Category 2 Bulk Drugs: Classified by FDA as having insufficient evidence for safety determination; compounding prohibited.
- WADA Prohibited: Use by athletes results in anti-doping violations and severe sanctions.
- Research Only: Intended solely for in vitro research, analytical studies, and non-clinical laboratory investigations by qualified researchers.
- Qualified Buyers Only: Sales restricted to verified research institutions with proper credentials, oversight, and end-use attestations.
- Buyer Responsibility: Purchasers assume full responsibility for compliance with all applicable laws, regulations, and institutional policies.
- No Warranty: Sold “as is” for research purposes only. No warranty for fitness for any particular purpose beyond laboratory research.
- Limitation of Liability: ALLUVI shall not be liable for any misuse, unauthorized use, or consequences arising from use outside of qualified research contexts.
- Indemnification: Buyers agree to indemnify and hold harmless ALLUVI from any claims arising from misuse or unauthorized use.
WARNING: Misuse of these peptides for human consumption presents unknown health risks including theoretical cancer promotion, immune system reactions, cardiovascular effects, and other serious adverse events. The safety and efficacy of these peptides in humans has NOT been established through rigorous clinical trials.
By purchasing these products, you acknowledge that you have read, understood, and agreed to comply with all terms, restrictions, and legal obligations outlined in this document and in the purchase agreement.
Mason Oliver –
Alluvi’s mix of BPC-157 and TB-500 performed beautifully, despite my doubts. I’m healing more quickly than before, and my joints feel smoother.
Anna Cathe –
Retatrutide, BPC, and TB-500 work incredibly well together. Between sessions, I feel more rested and slimmer.
James Gunn –
Alluvi’s mix of BPC-157 and TB-500 performed beautifully, despite my doubts. I’m healing more quickly than before, and my joints feel smoother.